Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Ocriplasmin 125µg
DRUG
2 trials
Sponsors
ThromboGenics
Conditions
Vitrectomy
Vitreomacular Adhesion
Phase 2
A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)
Completed
NCT00412958
ThromboGenics
Vitrectomy
Start: 2006-12-31
End: 2008-10-31
Updated: 2014-12-17
Phase 3
Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.
Completed
NCT00798317
ThromboGenics
Vitreomacular Adhesion
Start: 2008-12-31
End: 2010-07-31
Updated: 2014-12-17
Related Papers
Improvement in Patient-Reported Visual Function After Ocriplasmin for Vitreomacular Adhesion
JAMA Ophthalmology
2015-06-11
36 citations
Assessment of retinal morphology with spectral and time domain OCT in the phase III trials of enzymatic vitreolysis.
2012-10-25
15 citations
Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin.
2012-09-21
16 citations
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.
2012-08-01
371 citations